News

Multiple Sclerosis Treatment, Tecfidera, Seen to Ease Fibrosis and Inflammation in Early PAH Study

The approved multiple-sclerosis treatment Tecfidera was seen to improve pulmonary arterial hypertension (PAH) and inhibit lung fibrosis in mice by targeting multiple signaling pathways in a recent study. The research, “Dimethyl Fumarate ameliorates pulmonary arterial hypertension and lung fibrosis by targeting multiple pathways,” was published in the journal…

Actor Terrence Jenkins Expands Involvement in PH Media Campaign

Terrence Jenkins, second-year celebrity ambassador of the Pulmonary Hypertension Association (PHA), will appear in a print and digital public service ad campaign throughout 2017 to raise awareness about pulmonary hypertension (PH). Jenkins, better known as “Terrence J,” knows firsthand some of the frustrations of battling a rare disease like…

Training with Whole-body Vibration Device May Benefit PAH Patients, Trial Shows

Training with an oscillatory whole-body vibration (WBV) device may improve the exercise capacity, physical performance and quality of life of patients with pulmonary arterial hypertension (PAH), according to results of a new trial. The findings were published in an article titled “Oscillatory Whole-Body Vibration Improves Exercise Capacity And Physical Performance…

Vanderbilt Researcher Receives $6M to Study Pulmonary Hypertension, Other Heart Diseases

Dave Merryman, a researcher at Tennessee’s Vanderbilt University, has received $6 million to develop new treatments for pulmonary hypertension and other heart diseases. His research focuses on drugs initially intended to treat rheumatoid arthritis, and knowledge from failures of weight-loss drugs. Merryman, an associate professor of biomedical engineering, is currently developing treatments for heart…

Tracleer and Ventavis Combo as Initial Therapy Seen to Benefit Patients with Advanced PAH

An initial combination treatment with Tracleer (bosentan) and Ventavis (iloprost, inhalation solution) dramatically improved exercise capacity and clinical function in patients with pulmonary arterial hypertension (PAH), compared to treatment with either of those medications alone. The study, “Treatment of pulmonary arterial hypertension using initial combination therapy of…